Rockenstein E - Search Results

1

Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Vázquez-Roque RA, Ramos B, Tecuatl C, Juárez I, Adame A, de la Cruz F, Zamudio S, Mena R, Rockenstein E, Masliah E, Flores G. Vázquez-Roque RA, et al. Among authors: rockenstein e. J Neurosci Res. 2012 Jan;90(1):288-306. doi: 10.1002/jnr.22753. Epub 2011 Sep 19. J Neurosci Res. 2012. PMID: 21932359 Free PMC article.

2

Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo.

Masliah E, Westland CE, Rockenstein EM, Abraham CR, Mallory M, Veinberg I, Sheldon E, Mucke L. Masliah E, et al. Among authors: rockenstein em. Neuroscience. 1997 May;78(1):135-46. doi: 10.1016/s0306-4522(96)00553-2. Neuroscience. 1997. PMID: 9135095 Free article.

3

Differential neurotrophic effects of apolipoprotein E in aged transgenic mice.

Veinbergs I, Mallory M, Mante M, Rockenstein E, Gilbert JR, Masliah E. Veinbergs I, et al. Among authors: rockenstein e. Neurosci Lett. 1999 Apr 23;265(3):218-22. doi: 10.1016/s0304-3940(99)00243-8. Neurosci Lett. 1999. PMID: 10327170

4

In vitro synaptotrophic effects of Cerebrolysin in NT2N cells.

Mallory M, Honer W, Hsu L, Johnson R, Rockenstein E, Masliah E. Mallory M, et al. Among authors: rockenstein e. Acta Neuropathol. 1999 May;97(5):437-46. doi: 10.1007/s004010051012. Acta Neuropathol. 1999. PMID: 10334480

5

Genetically altered transgenic models of Alzheimer's disease.

Masliah E, Rockenstein E. Masliah E, et al. Among authors: rockenstein e. J Neural Transm Suppl. 2000;59:175-83. doi: 10.1007/978-3-7091-6781-6_20. J Neural Transm Suppl. 2000. PMID: 10961430 Review.

6

Altered expression of glutamate transporters under hypoxic conditions in vitro.

Hsu L, Rockenstein E, Mallory M, Hashimoto M, Masliah E. Hsu L, et al. Among authors: rockenstein e. J Neurosci Res. 2001 Apr 15;64(2):193-202. doi: 10.1002/jnr.1065. J Neurosci Res. 2001. PMID: 11288147

7

Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.

Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, Masliah E. Rockenstein E, et al. J Neurosci Res. 2002 Jun 1;68(5):568-78. doi: 10.1002/jnr.10231. J Neurosci Res. 2002. PMID: 12111846

8

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Windisch M, Hutter-Paier B, Rockenstein E, Hashimoto M, Mallory M, Masliah E. Windisch M, et al. Among authors: rockenstein e. J Mol Neurosci. 2002 Aug-Oct;19(1-2):63-9. doi: 10.1007/s12031-002-0012-8. J Mol Neurosci. 2002. PMID: 12212795

9

Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein.

Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E, Masliah E. Van Uden E, et al. Among authors: rockenstein e. J Neurosci. 2002 Nov 1;22(21):9298-304. doi: 10.1523/JNEUROSCI.22-21-09298.2002. J Neurosci. 2002. PMID: 12417655 Free PMC article.

10

Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.

Rockenstein E, Mallory M, Mante M, Alford M, Windisch M, Moessler H, Masliah E. Rockenstein E, et al. J Neural Transm Suppl. 2002;(62):327-36. J Neural Transm Suppl. 2002. PMID: 12456076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters